SCHEMBL30857940

SCHEMBL30857940

C=C(OCC)c1nc(C)cc2c(=O)cc(-c3ccncc3)oc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 6/20 0.47
▸ CYP1A1 P04798 6/20 0.47
▸ CYP1B1 Q16678 6/20 0.47
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ NCOA1 Q15788 1/20 0.45
▸ NCOA3 Q9Y6Q9 1/20 0.45
▸ CFTR P13569 2/20 0.45
▸ POLB P06746 1/20 0.45
▸ QPCT Q16769 1/20 0.41
▸ PIK3CD O00329 1/20 0.41
▸ PIK3CA P42336 1/20 0.41
▸ PIK3CB P42338 1/20 0.41
▸ PIK3CG P48736 1/20 0.41
▸ TNKS O95271 1/20 0.39
▸ CSNK2A2 P19784 4/20 0.38
▸ CSNK2B P67870 4/20 0.38
▸ CSNK2A1 P68400 4/20 0.38
▸ CDK4 P11802 1/20 0.37
▸ CCND1 P24385 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30857996 0.75 CYP1A1 (0.53) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
SCHEMBL30857984 0.71 PIK3CD (0.49) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
SCHEMBL6132108 0.67 PIK3CD (0.52) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
SCHEMBL910015 0.66 PIK3CD (0.57) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
SCHEMBL12904313 0.66 PIK3CD (0.56) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
SCHEMBL909776 0.66 PIK3CD (0.54) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
Alcohol SCHEMBL6005491 0.66 PIK3CD (0.56) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
Alcohol SCHEMBL6004304 0.66 PIK3CA (0.61) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
SCHEMBL910336 0.65 PIK3CD (0.67) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19
SCHEMBL6132106 0.65 PIK3CD (0.47) CYP1A2CYP1A1CYP1B1CYP3A4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4602031-A1 METHODS FOR TREATING CANCER Genesis Therapeutics, Inc. (US) 2025-08-20 — — EP disclosed
WO-2024081904-A1 METHODS FOR TREATING CANCER GENESIS THERAPEUTICS, INC. (US) 2024-04-18 — — WO disclosed
Send feedback